Pharmaceutical Combination
    86.
    发明申请
    Pharmaceutical Combination 有权
    药物组合

    公开(公告)号:US20110306674A1

    公开(公告)日:2011-12-15

    申请号:US13159845

    申请日:2011-06-14

    IPC分类号: A61K31/137 A61P29/00

    摘要: A pharmaceutical combination comprising as components (a) at least one 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol compound, and (b) at least one NMDA-antagonist, a pharmaceutical formulation and a dosage form comprising such a combination, and a method of treating pain, e.g. inflammatory pain or neuropathic pain, in which components (a) and (b) are administered simultaneously or sequentially to a mammal, with component (a) being administered either before or after component (b), and with components (a) or (b) being administered to the mammal either via the same pathway of administration or via different pathways of administration.

    摘要翻译: 一种药物组合,其包含作为组分(a)至少一种3-(3-二甲基氨基-1-乙基-2-甲基 - 丙基) - 酚化合物和(b)至少一种NMDA拮抗剂,药物制剂和剂量 包括这种组合的形式,以及治疗疼痛的方法,例如 其中组分(a)和(b)同时或依次施用于哺乳动物,其中组分(a)在组分(b)之前或之后施用,和组分(a)或(b )通过相同的给药途径或通过不同的给药途径施用于哺乳动物。